lunes, 16 de noviembre de 2026

Helus’ psychedelic drug improved depression in study but faces safety questions Helus is one of a number of companies pursuing psychedelics for depression

https://www.statnews.com/2026/11/16/helus-psychedelics-depression-phase-3-trial/ By Elaine ChenNov. 16, 2026 National Biotech Reporter

No hay comentarios:

Publicar un comentario